Delyon J, Bezier M, Cordoliani F, Malphettes M, Szalat R, Bagot M, Rybojad M
Service de dermatologie, hôpital Saint-Louis, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France.
Ann Dermatol Venereol. 2013 Jan;140(1):30-5. doi: 10.1016/j.annder.2012.10.599. Epub 2012 Dec 11.
Cryofibrinogenaemia is an under-recognized cutaneous thrombotic vasculopathy that may be revealed by purpura or chronic necrotic ulcerations. We report two original cases characterized by their severity, their association with a monoclonal gammopathy and their excellent response to treatment.
A 38-year-old woman was admitted for large necrotic leg ulcers appearing 1 year earlier and already investigated. Non-specific signs were seen on a previous skin biopsy and the diagnosis of a factitious disorder was considered at that time. Further investigations revealed circulating cryofibrinogen associated with IgG kappa monoclonal gammopathy without cryoglobulinaemia. Plasmapheresis followed by bortezomid-dexamethasone to treat the monoclonal gammopathy resulted in rapid and complete healing of the ulcers, militating in favour of its involvement in cryofibrinogen formation. The second patient, a 91-year-old woman, was referred to our department for acute necrotic purpura of the legs. Skin biopsy revealed leukocytoclastic vasculitis. Glomerular nephropathy with acute renal failure and multiple arterial thromboses were associated with the skin condition. The cryofibrinogen assay was positive without cryoglobulinaemia and other causes of vasculitis were ruled out. The main component was monoclonal IgG lambda. Prednisone-cyclophosphamide treatment led to complete healing of the skin lesions and to recovery from the systemic consequences of cryofibrinogen without sequelae.
Routine screening for cryofibrinogen in plasma should be performed to explore cutaneous symptoms of unexplained thrombotic vasculopathy, even in the presence of a non-specific skin biopsy. Specific treatment of cryofibrinogenaemia associated monoclonal gammopathy appears to be highly effective against manifestations of cryofibrinogenaemia.
冷纤维蛋白原血症是一种未得到充分认识的皮肤血栓性血管病,可表现为紫癜或慢性坏死性溃疡。我们报告两例具有严重性、与单克隆丙种球蛋白病相关且对治疗反应良好的原始病例。
一名38岁女性因1年前出现的大腿部大面积坏死性溃疡入院,此前已进行过检查。先前的皮肤活检未见特异性体征,当时考虑为人为性疾病。进一步检查发现循环冷纤维蛋白原与IgG κ单克隆丙种球蛋白病相关,无冷球蛋白血症。采用血浆置换,随后使用硼替佐米-地塞米松治疗单克隆丙种球蛋白病,溃疡迅速完全愈合,提示其参与冷纤维蛋白原的形成。第二例患者为一名91岁女性,因双下肢急性坏死性紫癜转诊至我科。皮肤活检显示白细胞破碎性血管炎。肾小球肾病伴急性肾衰竭和多处动脉血栓形成与皮肤病变相关。冷纤维蛋白原检测呈阳性,无冷球蛋白血症,排除了其他血管炎病因。主要成分是单克隆IgG λ。泼尼松-环磷酰胺治疗使皮肤病变完全愈合,冷纤维蛋白原血症的全身后果得以恢复,且无后遗症。
对于不明原因的血栓性血管病的皮肤症状,即使皮肤活检无特异性表现,也应进行血浆冷纤维蛋白原的常规筛查。与冷纤维蛋白原血症相关的单克隆丙种球蛋白病的特异性治疗似乎对冷纤维蛋白原血症的表现非常有效。